New guidelines to assess cardiac risk before using stimulant medication in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) were published concurrently in 3 Canadian medical society journals in November. Publication of these guidelines coincided with an FDA announcement of a delay in a US epidemiological study of the potential cardiovascular risk.
7 Vote(s)
January 13, 2010
Cardiac Risk of Stimulants for Children With ADHD:
Comments Off